LPCN - Lipocine regains compliance with Nasdaq listing rule July, 13 2020 08:09 AM Lipocine Inc. Lipocine (NASDAQ:LPCN) has regained compliance with Nasdaq minimum bid price requirement of $1.00 for continued listing.More news on: Lipocine Inc., Stocks on the move, Healthcare stocks news, Read more ...